1. Home
  2. NMRA vs API Comparison

NMRA vs API Comparison

Compare NMRA & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • API
  • Stock Information
  • Founded
  • NMRA 2019
  • API 2013
  • Country
  • NMRA United States
  • API United States
  • Employees
  • NMRA N/A
  • API N/A
  • Industry
  • NMRA
  • API Computer Software: Prepackaged Software
  • Sector
  • NMRA
  • API Technology
  • Exchange
  • NMRA Nasdaq
  • API Nasdaq
  • Market Cap
  • NMRA 287.6M
  • API 283.7M
  • IPO Year
  • NMRA 2023
  • API 2020
  • Fundamental
  • Price
  • NMRA $0.66
  • API $3.37
  • Analyst Decision
  • NMRA Buy
  • API Strong Buy
  • Analyst Count
  • NMRA 8
  • API 1
  • Target Price
  • NMRA $9.29
  • API $6.00
  • AVG Volume (30 Days)
  • NMRA 891.0K
  • API 820.8K
  • Earning Date
  • NMRA 05-12-2025
  • API 05-27-2025
  • Dividend Yield
  • NMRA N/A
  • API N/A
  • EPS Growth
  • NMRA N/A
  • API N/A
  • EPS
  • NMRA N/A
  • API N/A
  • Revenue
  • NMRA N/A
  • API $133,256,000.00
  • Revenue This Year
  • NMRA N/A
  • API $6.89
  • Revenue Next Year
  • NMRA N/A
  • API $10.96
  • P/E Ratio
  • NMRA N/A
  • API N/A
  • Revenue Growth
  • NMRA N/A
  • API N/A
  • 52 Week Low
  • NMRA $0.62
  • API $1.65
  • 52 Week High
  • NMRA $17.19
  • API $6.99
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 31.99
  • API 47.08
  • Support Level
  • NMRA $0.63
  • API $3.24
  • Resistance Level
  • NMRA $0.72
  • API $3.53
  • Average True Range (ATR)
  • NMRA 0.06
  • API 0.20
  • MACD
  • NMRA 0.02
  • API 0.11
  • Stochastic Oscillator
  • NMRA 18.80
  • API 77.45

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: